The volume of commercial retail market of anti-influenza drugs in the first half of 2017 amounted to 24.3 billion rubles (+ 0.4%) and 70.3 million packages (-2.7%)
The capacity of the business segment of the pharmacy market (medicinal products, dietary supplements, and pharmacy sideline) in the first half of 2017 reached 545.83 billion rubles in the prices of pharmacy sales, which is 12.7% higher than in the same period of the last year. By volume, about 3.4 billion packages were sold, which is 10% more than in the same period in 2016.
Regional and federal networks had the largest profit (difference between the sales at Sell-out and Sell-in) in the first half of 2017, and the local chains can be considered as outsiders based on this parameter. In the years of crisis, the local level networks and smaller pharmacy chains were affected much more than regional and federal ones, which reached the highest profits in the considered period of the first half of 2017, while the local chains’ situation became worse than it was during the crisis
Based on the results of the 2nd quarter of 2016 to 1st quarter of 2017, the sales of intestinal adsorbent medicinal products in pharmacies amounted to 8.03 billion rubles², which meant that 0.11 billion packages were sold. The sales increased by + 4% in value and + 13% in packages (Figure 1).
Overview of pharmacy sales of medicinal products for the treatment of influenza based on the results of the first half of 2017
The volume of commercial retail market of anti-influenza drugs in the first half of 2017 amounted to 24.3 billion rubles (+ 0.4%) and 70.3 million packages (-2.7%)